Cover
Obituary
Foreword
Preface
Contributors to Volume 84
Contents
30 Physical therapy in Parkinson's disease.pdf
31 Neuroprotection in Parkinson's disease- clinical trials.pdf
32 Levodopa.pdf
33 Dopamine agonists.pdf
34 Monoamine oxidase A and B inhibitors in Parkinson's disease.pdf
35 Anticholinergic medications.pdf
36 Antiglutamatergic drugs in the treatment of Parkinson's disease.pdf
37 Investigational drugs.pdf
38 The importance of patient groups and collaboration.pdf
39 Motor and non-motor fluctuations.pdf
40 Levodopa-induced dyskinesias in Parkinson's disease.pdf
41 Treatment-induced mental changes in Parkinson's disease.pdf
42 Ablative surgery for the treatment of Parkinson's disease.pdf
43 Deep brain stimulation.pdf
44 Transplantation.pdf
45 Gene therapy approaches for the treatment of Parkinson's disease.pdf
46 Multiple system atrophy.pdf
47 Progressive supranuclear palsy.pdf
48 Corticobasal degeneration.pdf
49 Infectious basis to the pathogenesis of Parkinson's disease.pdf
50 Toxic causes of parkinsonism.pdf
51 Drug-induced parkinsonism.pdf
52 Vascular parkinsonism.pdf
53 Old age and Parkinson's disease.pdf
54 Other degenerative processes.pdf
55 Hydrocephalus and structural lesions.pdf
56 Calcification of the basal ganglia.pdf
57 Trauma and Parkinson's disease.pdf
58 Psychogenic parkinsonism.pdf
59 Parkinsonism and dystonia.pdf
60 Dementia with Lewy bodies.pdf
61 Myoclonus and parkinsonism.pdf
Subject Index